Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human organ transplantation.

I Karlberg, T Scherstén

    World Health Forum
    |January 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Organ transplantation offers improved survival for end-stage organ disease. However, challenges like rejection and the complexity of artificial organ function mean transplantation remains an evolving field.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The synthesis of taurocholic and glycocholic acids in human liver homogenates and subcellular fractions in obstructive jaundice.

    Scandinavian journal of gastroenterology·2010
    Same author

    Integrated care for the elderly: the background and effects of the reform of Swedish care of the elderly.

    International journal of integrated care·2006
    Same author

    Health technology assessment and screening in Sweden.

    International journal of technology assessment in health care·2001
    Same author

    Lack of integration, and seasonal variations in demand explained performance problems and waiting times for patients at emergency departments: a 3 years evaluation of the shift of responsibility between primary and secondary care by closure of two acute hospitals.

    Health policy (Amsterdam, Netherlands)·2001
    Same author

    Implementation of service screening with mammography in Sweden: from pilot study to nationwide programme.

    Journal of medical screening·2000
    Same author

    Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia, tumour necrosis factor alpha and melphalan.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·1999
    Same journal

    Maternal and child health in the 1950s and 1960s.

    World health forum·1999
    Same journal

    From general hospital to Baby-Friendly hospital.

    World health forum·1999
    Same journal

    Use of hammocks in a rural hospital.

    World health forum·1999
    Same journal

    Indicators of social and mental health.

    World health forum·1999
    Same journal

    Deaths from cholera.

    World health forum·1999
    Same journal

    Dying with dignity.

    World health forum·1999
    See all related articles

    Area of Science:

    • Medical Science
    • Surgical Innovation
    • Immunology

    Background:

    • Organ transplantation is a vital treatment for end-stage organ failure, improving patient survival and rehabilitation.
    • Graft rejection remains a significant complication, despite advances in immunosuppressive therapies.
    • Current artificial organ technology cannot fully replicate the complex metabolic functions of biological organs.

    Purpose of the Study:

    • To review the current status and future prospects of organ transplantation.
    • To discuss the challenges and limitations of artificial organ development.
    • To highlight the ongoing evolution of transplantation as a therapeutic strategy.

    Main Methods:

    • Literature review of transplantation outcomes and artificial organ research.

    Related Experiment Videos

  • Analysis of the metabolic complexities of key organs (heart, liver, kidney).
  • Discussion of immunosuppression advancements and their impact on transplantation.

    • Main Results:

    • Transplantation significantly extends survival for patients with end-stage organ disease.
    • Specific immunosuppression shows promise for reducing rejection with fewer side effects.
    • Artificial organ development faces significant hurdles in replicating in vivo metabolic feedback.

    Conclusions:

    • Organ transplantation is a crucial, albeit evolving, technology for treating end-stage organ failure.
    • The intricate metabolic roles of organs like the heart, liver, and kidney limit near-term artificial replacement feasibility.
    • Continued research in immunosuppression and bioengineering is essential for advancing transplantation.